DNA Link Inc Capital Reinvestment Ratio
DNA Link Inc capital reinvestment ratio. DNA Link Inc (127120) has a Capital Reinvestment Ratio of 0.52x as of December 2023, meaning it reinvests 1% of its operating cash flow (₩1.51 Billion) in capital expenditures (₩786.91 Million). See how much free cash does DNA Link Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of DNA Link Inc (2020–2022)
Capital reinvestment ratio of DNA Link Inc from 2020 to 2022. This chart tracks DNA Link Inc's Capital Reinvestment Ratio across 2 annual periods. See 127120 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
DNA Link Inc Capital Reinvestment Ratio by Year (2020–2022)
DNA Link Inc capital reinvestment ratio by year from 2020 to 2022. For the full cash flow conversion analysis, see DNA Link Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 5.42x | ₩910.27 Million | ₩4.93 Billion | ▲ +319.1% |
| 2020 | 1.29x | ₩849.38 Million | ₩1.10 Billion | — |